Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
Background: there is little evidence about the relationship between aetiology, illness severity, and clinical course of respiratory tract infections (RTIs) in primary care. Understanding these associations would aid in the development of effective management strategies for these infections.
Aim: to investigate whether clinical presentation and illness course differ between RTIs where a viral pathogen was detected and those where a potential bacterial pathogen was found.
Design and setting: post hoc analysis of data from a pragmatic randomised trial on the effects of oseltamivir in patients with flu-like illness in primary care (n = 3266) in 15 European countries.
Method: patient characteristics and their signs and symptoms of disease were registered at baseline. Nasopharyngeal (adults) or nasal and pharyngeal (children) swabs were taken for polymerase chain reaction analysis. Patients were followed up until 28 days after inclusion. Regression models and Kaplan-Meier curves were used to analyse the relationship between aetiology, clinical presentation at baseline, and course of disease including complications.
Results: except for a less prominent congested nose (odds ratio [OR] 0.55, 95% confidence interval [CI] = 0.35 to 0.86) and acute cough (OR 0.42, 95% CI = 0.27 to 0.65) in patients with flu-like illness in whom a possible bacterial pathogen was isolated, there were no clear clinical differences in presentations between those with a possible bacterial aetiology compared with those with a viral aetiology. Also, course of disease and complications were not related to aetiology.
Conclusion: given current available microbiological tests and antimicrobial treatments, and outside pandemics such as COVID-19, microbiological testing in primary care patients with flu-like illness seems to have limited value. A wait-and-see policy in most of these patients with flu-like illness seems the best option.
Diagnosis, Oseltamivir, Primary health care, Randomised controlled trial, Respiratory tract infections
e217-e224
Verheij, Theo J.
0164f6e4-2c95-4233-8c2e-29b616c8ff66
Cianci, Daniela
7790704f-ce14-4ee6-8d01-a21757bb3481
van der Velden, Alike W
23e7518e-85f9-4a8b-b2d9-76904ae79116
Butler, Christopher C
8bf4cace-c34a-4b65-838f-29c2be91e434
Bongard, Emily
9ed23288-21b5-4fc4-b6a7-8340096f84ca
Coenen, Samuel
3d0dc4e0-e5ba-4d66-ba92-15900ccc551e
Colliers, Annelies
45b9ab29-7065-407e-bab1-86afc6bfc72c
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Godycki-Cwirko, Maciek
306b5836-4955-470d-bf1f-77c6ac282138
Llor, Carl
a7fcfced-28f4-4771-8ca5-2c1ce2095d61
Chlabicz, Sławomir
554ddde7-9bc6-40ce-b9c9-bdf1336c0eea
Lionis, Christos
458b4c43-ceff-4226-820d-c3db2cc8d08b
Sundvall, Pär-Daniel
261d1590-e63e-4617-b7cd-956b081614b0
Bjerrum, Lars
a2c03a01-2dfe-4564-a95b-f750cf51be86
De Sutter, An
9114cd76-97bf-43c0-9dad-928318cea259
Aabenhus, Rune
7717d1b9-aa1e-4bc6-8d64-0408abadd367
Harbin, Nicolay Jonassen
66088626-ec3b-4f14-9ca8-7a1e63e8dfdf
Lindbæk, Morten
dca528be-e82b-4c7d-b5d5-d776cf45d901
Glinz, Dominik
be3fe745-c877-4433-9b34-6bfbc6728ad7
Bucher, Heiner C.
e38c2e7f-86af-4ecd-a798-e9510ce9a599
Kovács, Bernadett
b66ddc00-9745-49a3-ab29-50e2f6584077
Seifert, Bohumil
4a20a9c5-d41a-4fef-932d-9a78199526ff
Jurgute, Ruta Radzeviciene
c02e91e1-08a2-4bc0-979f-b422ede1a36c
Lundgren, Pia Touboul
09ca2cae-b6cf-470c-962c-fa46ff61fdcb
de Paor, Muireann
be4e96a0-e077-4d55-a1e3-8620a24494e0
Matheeussen, Veerle
2aa034a4-d519-4b94-b610-644a0a9fa9dc
Goossens, Herman
31f8e1ae-7da0-473c-bd49-f911c2187451
Ieven, Margareta
c138048d-d838-4c8e-848d-a43e309f4cf0
March 2022
Verheij, Theo J.
0164f6e4-2c95-4233-8c2e-29b616c8ff66
Cianci, Daniela
7790704f-ce14-4ee6-8d01-a21757bb3481
van der Velden, Alike W
23e7518e-85f9-4a8b-b2d9-76904ae79116
Butler, Christopher C
8bf4cace-c34a-4b65-838f-29c2be91e434
Bongard, Emily
9ed23288-21b5-4fc4-b6a7-8340096f84ca
Coenen, Samuel
3d0dc4e0-e5ba-4d66-ba92-15900ccc551e
Colliers, Annelies
45b9ab29-7065-407e-bab1-86afc6bfc72c
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Godycki-Cwirko, Maciek
306b5836-4955-470d-bf1f-77c6ac282138
Llor, Carl
a7fcfced-28f4-4771-8ca5-2c1ce2095d61
Chlabicz, Sławomir
554ddde7-9bc6-40ce-b9c9-bdf1336c0eea
Lionis, Christos
458b4c43-ceff-4226-820d-c3db2cc8d08b
Sundvall, Pär-Daniel
261d1590-e63e-4617-b7cd-956b081614b0
Bjerrum, Lars
a2c03a01-2dfe-4564-a95b-f750cf51be86
De Sutter, An
9114cd76-97bf-43c0-9dad-928318cea259
Aabenhus, Rune
7717d1b9-aa1e-4bc6-8d64-0408abadd367
Harbin, Nicolay Jonassen
66088626-ec3b-4f14-9ca8-7a1e63e8dfdf
Lindbæk, Morten
dca528be-e82b-4c7d-b5d5-d776cf45d901
Glinz, Dominik
be3fe745-c877-4433-9b34-6bfbc6728ad7
Bucher, Heiner C.
e38c2e7f-86af-4ecd-a798-e9510ce9a599
Kovács, Bernadett
b66ddc00-9745-49a3-ab29-50e2f6584077
Seifert, Bohumil
4a20a9c5-d41a-4fef-932d-9a78199526ff
Jurgute, Ruta Radzeviciene
c02e91e1-08a2-4bc0-979f-b422ede1a36c
Lundgren, Pia Touboul
09ca2cae-b6cf-470c-962c-fa46ff61fdcb
de Paor, Muireann
be4e96a0-e077-4d55-a1e3-8620a24494e0
Matheeussen, Veerle
2aa034a4-d519-4b94-b610-644a0a9fa9dc
Goossens, Herman
31f8e1ae-7da0-473c-bd49-f911c2187451
Ieven, Margareta
c138048d-d838-4c8e-848d-a43e309f4cf0
Verheij, Theo J., Cianci, Daniela, van der Velden, Alike W, Butler, Christopher C, Bongard, Emily, Coenen, Samuel, Colliers, Annelies, Francis, Nick A., Little, Paul, Godycki-Cwirko, Maciek, Llor, Carl, Chlabicz, Sławomir, Lionis, Christos, Sundvall, Pär-Daniel, Bjerrum, Lars, De Sutter, An, Aabenhus, Rune, Harbin, Nicolay Jonassen, Lindbæk, Morten, Glinz, Dominik, Bucher, Heiner C., Kovács, Bernadett, Seifert, Bohumil, Jurgute, Ruta Radzeviciene, Lundgren, Pia Touboul, de Paor, Muireann, Matheeussen, Veerle, Goossens, Herman and Ieven, Margareta
(2022)
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data.
The British journal of general practice : the journal of the Royal College of General Practitioners, 72 (716), .
(doi:10.3399/BJGP.2021.0344).
Abstract
Background: there is little evidence about the relationship between aetiology, illness severity, and clinical course of respiratory tract infections (RTIs) in primary care. Understanding these associations would aid in the development of effective management strategies for these infections.
Aim: to investigate whether clinical presentation and illness course differ between RTIs where a viral pathogen was detected and those where a potential bacterial pathogen was found.
Design and setting: post hoc analysis of data from a pragmatic randomised trial on the effects of oseltamivir in patients with flu-like illness in primary care (n = 3266) in 15 European countries.
Method: patient characteristics and their signs and symptoms of disease were registered at baseline. Nasopharyngeal (adults) or nasal and pharyngeal (children) swabs were taken for polymerase chain reaction analysis. Patients were followed up until 28 days after inclusion. Regression models and Kaplan-Meier curves were used to analyse the relationship between aetiology, clinical presentation at baseline, and course of disease including complications.
Results: except for a less prominent congested nose (odds ratio [OR] 0.55, 95% confidence interval [CI] = 0.35 to 0.86) and acute cough (OR 0.42, 95% CI = 0.27 to 0.65) in patients with flu-like illness in whom a possible bacterial pathogen was isolated, there were no clear clinical differences in presentations between those with a possible bacterial aetiology compared with those with a viral aetiology. Also, course of disease and complications were not related to aetiology.
Conclusion: given current available microbiological tests and antimicrobial treatments, and outside pandemics such as COVID-19, microbiological testing in primary care patients with flu-like illness seems to have limited value. A wait-and-see policy in most of these patients with flu-like illness seems the best option.
Text
e217.full
- Version of Record
More information
Accepted/In Press date: 4 October 2021
e-pub ahead of print date: 24 February 2022
Published date: March 2022
Additional Information:
Funding Information:
Christopher C Butler reports grants from the National Institute for Health Research (NIHR) Health as NIHR Senior Investigator, grants from the NIHR Health Technology Assessment Programme to support the study, grants from NIHR Health Protection Research Unit on Health Care Associated Infections and Antimicrobial Resistance, grants from NIHR Health for the MedTech and In Vitro Diagnostics Cooperative for innovative diagnostics and monitoring technology to enhance community health care during the conduct of the study, personal fees from Pfizer and Roche Molecular Systems, and grants from Roche Molecular Diagnostics. Alike W van der Velden reports personal fees from Reckitt Benckiser. Christos Lionis reports grants from Abbott Diagnostics. Heiner C Bucher or his Institute has received, in the 36 months before the submission of this manuscript, grants, support for travelling, consultancy fees, and honoraria from Gilead, Bristol Myers Squibb, ViiV Healthcare, Idorsia, and Roche, outside the submitted work. He serves as the President of the Association Contre le HIV et Autres Infections Transmissibles. In this function he has received support from the Swiss HIV Cohort Study from ViiV Healthcare, Gilead, Bristol Myers Squibb, Merck Sharp & Dohme, and AbbVie. Theo J Verheij reports grants from the NIHR, Netherlands Organization of Health Research and Development, and the EU Innovative Medicines Initiative, which has Janssen Pharmaceuticals, Biocartis, bioMérieux, and Berry Consultants as partners, all outside the submitted work. All other authors have declared no competing interests.
Publisher Copyright:
© 2022 Royal College of General Practitioners. All rights reserved.
Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.
Keywords:
Diagnosis, Oseltamivir, Primary health care, Randomised controlled trial, Respiratory tract infections
Identifiers
Local EPrints ID: 455345
URI: http://eprints.soton.ac.uk/id/eprint/455345
ISSN: 0960-1643
PURE UUID: 04f84623-024c-434c-b5ae-03561a219ee1
Catalogue record
Date deposited: 17 Mar 2022 17:36
Last modified: 17 Mar 2024 03:58
Export record
Altmetrics
Contributors
Author:
Theo J. Verheij
Author:
Daniela Cianci
Author:
Alike W van der Velden
Author:
Christopher C Butler
Author:
Emily Bongard
Author:
Samuel Coenen
Author:
Annelies Colliers
Author:
Maciek Godycki-Cwirko
Author:
Carl Llor
Author:
Sławomir Chlabicz
Author:
Christos Lionis
Author:
Pär-Daniel Sundvall
Author:
Lars Bjerrum
Author:
An De Sutter
Author:
Rune Aabenhus
Author:
Nicolay Jonassen Harbin
Author:
Morten Lindbæk
Author:
Dominik Glinz
Author:
Heiner C. Bucher
Author:
Bernadett Kovács
Author:
Bohumil Seifert
Author:
Ruta Radzeviciene Jurgute
Author:
Pia Touboul Lundgren
Author:
Muireann de Paor
Author:
Veerle Matheeussen
Author:
Herman Goossens
Author:
Margareta Ieven
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
